UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021478
Receipt number R000024775
Scientific Title Efficacy and safety of Descemet membrane endothelial keratoplasty (DMEK) for bullous keratopathy
Date of disclosure of the study information 2016/03/17
Last modified on 2021/10/19 14:10:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy and safety of Descemet membrane endothelial keratoplasty (DMEK) for bullous keratopathy

Acronym

Evaluation of Descemet membrane endothelial keratoplasty (DMEK)

Scientific Title

Efficacy and safety of Descemet membrane endothelial keratoplasty (DMEK) for bullous keratopathy

Scientific Title:Acronym

Evaluation of Descemet membrane endothelial keratoplasty (DMEK)

Region

Japan


Condition

Condition

Bullous keratopathy

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate efficacy and safety of Descemet membrane endothelial keratoplasty (DMEK).

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Visual acuity

Key secondary outcomes

Keratometry
Endothelial cell density
Pachymetry


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Descemet membrane endothelial keratoplasty (DMEK)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with bullous keratopathy

Key exclusion criteria

Aphakia
Severe corneal stromal opacity

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Yu
Middle name
Last name Monden

Organization

Kurume University School of Medicine

Division name

Department of Ophthalmology

Zip code

830-0011

Address

67 Asahi-machi, Kurume 830-0011, Japan.

TEL

0942317574

Email

you@med.kurume-u.ac.jp


Public contact

Name of contact person

1st name Yu
Middle name
Last name Monden

Organization

Kurume University School of Medicine

Division name

Department of Ophthalmology

Zip code

830-0011

Address

67 Asahi-machi, Kurume 830-0011, Japan.

TEL

0942317574

Homepage URL


Email

you@med.kurume-u.ac.jp


Sponsor or person

Institute

Kurume University

Institute

Department

Personal name



Funding Source

Organization

Kurume University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Clinical Research Center, Kurume University Hospital

Address

67 Asahi-machi, Kurume 830-0011, Japan.

Tel

0942-31-7200

Email

i_rinri@kurume-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

久留米大学病院(福岡県)


Other administrative information

Date of disclosure of the study information

2016 Year 03 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2016 Year 02 Month 16 Day

Date of IRB

2016 Year 02 Month 16 Day

Anticipated trial start date

2016 Year 03 Month 17 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 03 Month 15 Day

Last modified on

2021 Year 10 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024775


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name